Ticker
PROKCompany Name
PROKIDNEY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures to Operating Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 32.16M | 0% | $ -114.42M |
3/31/2025 | $ 29.68M | 0% | $ -121.3M |
12/31/2024 | $ 29.51M | 0% | $ -126.35M |
9/30/2024 | $ 5.57M | 0% | $ -127.56M |
6/30/2024 | $ 31.11M | 0% | $ -122.1M |
3/31/2024 | $ 34.17M | 0% | $ -98.72M |
12/31/2023 | $ 34.2M | 0% | $ -90.07M |
9/30/2023 | $ 32.93M | 0% | $ -80.45M |
6/30/2023 | $ 5.31M | 1.14% | $ 464.94M |
3/31/2023 | $ 1.61M | 0% | $ -87.62M |
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for PROKIDNEY CORP is calculated as follows: CapEx [ $ 0 ] / CF - Operations [ $ -1.21M ]
(=) CapEx/OCF [ 0% ]
Minimum
Jun 30, 2023
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 2.35K |
---|---|
min | 0.01% |
max | 128% |
average | 31.8% |
median | 22.41% |
std | 29.52% |